Author | Michael Schröder, MD

Articles

UFT/Leucovorin Plus Weekly Paclitaxel in the Treatment of Solid Tumors

October 01, 2000

The palliation of symptoms and improvement of quality of life are important aspects of therapy in patients with incurable metastatic cancer. This article describes the preliminary results of a phase I study of uracil and tegafur, an orally available fluorouracil (5-FU) derivative combined with oral leucovorin plus weekly intravenous paclitaxel.